Budd Larner Ranked Third Among All Hatch Waxman Defense Firms

Budd Larner, PC, has been recognized as one of the top three defense firms for ANDA litigation in Lex Machina’s 2017 Hatch-Waxman/ANDA Litigation Report. The report surveys the patent litigation landscape related to ANDAs submitted to the U.S. Food and Drug Administration under the Hatch-Waxman Act, covering cases filed in U.S. district courts between January 1, 2009 and March 31, 2017. Budd Larner is listed third on the list with 35 cases.

Budd Larner has one of the leading Hatch-Waxman Litigation practices in the country, with more than two dozen attorneys and scientific advisors who spend full-time representing the generic pharmaceutical industry in ANDA work. Led by Andrew J. Miller, the team has worked on hundreds of ANDA products over the years.

“We appreciate that our generic drug clients have placed their trust in us for many years to handle these extremely important cases”, said Miller, Chair of Budd Larner’s Intellectual Property Group.